/Investor DB

Artis Ventures — 2019 Investments

2 investments dated 2019 · listed companies and verified rows first · show all

Unnatural Productsunnaturalproducts.comin𝕏Seed · Sep 2019 · $6M

Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.

AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US

Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in

Board seatVasudev Bailey· per SEC Form D

Co-investorsAbstract VenturesAsset Management CompanyBetter Ventures Central LlcBlue Bear VenturesColorcon VenturesDroia Ventures+9 more

Enkluenklu.comJun 2019

Enklu develops Verse, a location-based attraction platform for venue, resort, and entertainment center operators to create social entertainment experiences.

GamingAlameda, US

Raymond Kallmeyer(Founder)in

Co-investorsBrincEspt Ventures LlcIrishAngelsMotivate Venture Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.